
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-02-04-2015
- Volume 11
- Issue 2
SAFC Expands Irvine Facility
The new facility will feature dry powder cell-culture media capabilities.
SAFC Commercial, a branch of the Sigma-Aldrich Corporation, recently announced they are expanding their facility capabilities to provide redundancy to the dry powder manufacturing supply chain. The dry-powder milling and blending for cell-culture media that occurs at the Lenexa, Kansas facility will also occur in the Irvine, Scotland locations. Liquid cell-culture media, buffers, and reagents are already prepared at the Irvine site.
According to a press release, the facility expansion will allow SAFC to create shorter lead times, increase storage capacity for finished goods, and support projects from “early clinical development through commercial scale using a globally consistent approach across all cell culture media manufacturing sites,” said Gilles Cottier, president of SAFC.
Source:
Articles in this issue
almost 11 years ago
Technology Improvements Drive Capacity Gains for Biologics Fill/Finishalmost 11 years ago
New Excipient Options for Oral Solid Dosage Drugsalmost 11 years ago
Extending Shelf Life through Better Blister Package Designsalmost 11 years ago
More Growth Expected for API Custom Manufacturing in 2015almost 11 years ago
Catalent Expands High-Potency Handling Capabilityalmost 11 years ago
PPD Announces Completion of Clinical Studies Facility in Irelandalmost 11 years ago
Ash Stevens to Manufacture Amotosalen APIalmost 11 years ago
FUJIFILM Diosynth Begins Work on Bioprocess Innovation Centeralmost 11 years ago
AMRI Acquires Two Aptuit FacilitiesNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





